Search research articles
Contact Us
Filters
Showing results (41-50 of 176) with videos related to
Page
of 18
Sort By:
Leukemia & Lymphoma
|
June 7, 2012
Macrophage, mast cell and T lymphocyte infiltrations are independent predictive biomarkers of primary refractoriness or early relapse in classical Hodgkin lymphoma
Bénédicte Deau, Emmanuel Bachy, Vincent Ribrag, et al.
Investigational New Drugs
|
January 21, 2015
Phase 1 study of the oral histone deacetylase inhibitor abexinostat in patients with Hodgkin lymphoma, non-Hodgkin lymphoma, or chronic lymphocytic leukaemia
Franck Morschhauser, Louis Terriou, Bertrand Coiffier, et al.
Frontiers in Immunology
|
February 27, 2019
Residual Activatability of Circulating Tfh17 Predicts Humoral Response to Thymodependent Antigens in Patients on Therapeutic Immunosuppression
Suzan Dahdal, Carole Saison, Martine Valette, et al.
Cancer Chemotherapy and Pharmacology
|
September 23, 2015
Etoposide pharmacokinetics impact the outcomes of lymphoma patients treated with BEAM regimen and ASCT: a multicenter study of the LYmphoma Study Association (LYSA)
Benoit You, Gilles Salles, Emmanuel Bachy, et al.
Scientific Reports
|
April 20, 2023
Deciphering the spectrum of cutaneous lymphomas expressing TFH markers
Marie Donzel, Alexis Trecourt, Brigitte Balme, et al.
British Journal of Haematology
|
October 23, 2024
Conditional survival of younger patients with mantle cell lymphoma: Results from a randomized phase III trial of the European MCL Network
Linmiao Jiang, Martin Dreyling, Olivier Hermine, et al.
Blood
|
November 4, 2018
Chronic <i>Borrelia burgdorferi</i> infection triggers NKT lymphomagenesis
Rémy Robinot, Emmanuel Bachy, Sammara Chaubard, et al.
Kidney International
|
June 27, 2013
Maintaining calcineurin inhibition after the diagnosis of post-transplant lymphoproliferative disorder improves renal graft survival
Jean-Emmanuel Serre, David Michonneau, Emmanuel Bachy, et al.
Frontiers in Oncology
|
July 25, 2025
Patient and physician treatment preferences in relapsed/refractory follicular lymphoma: a discrete choice experiment in the United States, United Kingdom, France, Germany, Brazil, and Japan
John G Gribben, Emmanuel Bachy, Markqayne Ray, et al.
Leukemia & Lymphoma
|
December 27, 2022
Flare-up phenomenon or pseudoprogression after CAR T-cell infusion in non-Hodgkin aggressive lymphomas
Clara Sortais, Stéphanie Cordeil, Estelle Bourbon, et al.
Page
of 18
Search research articles
Search
Showing results (41-50 of 176) with videos related to
Sort By:
Page
of 18
Leukemia & Lymphoma
|
June 7, 2012
Macrophage, mast cell and T lymphocyte infiltrations are independent predictive biomarkers of primary refractoriness or early relapse in classical Hodgkin lymphoma
Bénédicte Deau, Emmanuel Bachy, Vincent Ribrag, et al.
Investigational New Drugs
|
January 21, 2015
Phase 1 study of the oral histone deacetylase inhibitor abexinostat in patients with Hodgkin lymphoma, non-Hodgkin lymphoma, or chronic lymphocytic leukaemia
Franck Morschhauser, Louis Terriou, Bertrand Coiffier, et al.
Frontiers in Immunology
|
February 27, 2019
Residual Activatability of Circulating Tfh17 Predicts Humoral Response to Thymodependent Antigens in Patients on Therapeutic Immunosuppression
Suzan Dahdal, Carole Saison, Martine Valette, et al.
Cancer Chemotherapy and Pharmacology
|
September 23, 2015
Etoposide pharmacokinetics impact the outcomes of lymphoma patients treated with BEAM regimen and ASCT: a multicenter study of the LYmphoma Study Association (LYSA)
Benoit You, Gilles Salles, Emmanuel Bachy, et al.
Scientific Reports
|
April 20, 2023
Deciphering the spectrum of cutaneous lymphomas expressing TFH markers
Marie Donzel, Alexis Trecourt, Brigitte Balme, et al.
British Journal of Haematology
|
October 23, 2024
Conditional survival of younger patients with mantle cell lymphoma: Results from a randomized phase III trial of the European MCL Network
Linmiao Jiang, Martin Dreyling, Olivier Hermine, et al.
Blood
|
November 4, 2018
Chronic <i>Borrelia burgdorferi</i> infection triggers NKT lymphomagenesis
Rémy Robinot, Emmanuel Bachy, Sammara Chaubard, et al.
Kidney International
|
June 27, 2013
Maintaining calcineurin inhibition after the diagnosis of post-transplant lymphoproliferative disorder improves renal graft survival
Jean-Emmanuel Serre, David Michonneau, Emmanuel Bachy, et al.
Frontiers in Oncology
|
July 25, 2025
Patient and physician treatment preferences in relapsed/refractory follicular lymphoma: a discrete choice experiment in the United States, United Kingdom, France, Germany, Brazil, and Japan
John G Gribben, Emmanuel Bachy, Markqayne Ray, et al.
Leukemia & Lymphoma
|
December 27, 2022
Flare-up phenomenon or pseudoprogression after CAR T-cell infusion in non-Hodgkin aggressive lymphomas
Clara Sortais, Stéphanie Cordeil, Estelle Bourbon, et al.
Page
of 18